| EP4100072 - INJECTABLE IN VIVO CROSSLINKING MATERIALS FOR USE AS SOFT TISSUE FILLERS [Right-click to bookmark this link] | Status | Grant of patent is intended Status updated on 01.02.2026 Database last updated on 09.04.2026 | |
| Former | Examination is in progress Status updated on 03.10.2024 | ||
| Former | Request for examination was made Status updated on 11.11.2022 | ||
| Former | The international publication has been made Status updated on 13.08.2021 | ||
| Former | unknown Status updated on 10.03.2021 | Most recent event Tooltip | 20.02.2026 | New entry: Renewal fee paid | Applicant(s) | For all designated states Boston Scientific Scimed Inc. One Scimed Place Maple Grove, Minnesota 55311 / US | [2022/50] | Inventor(s) | 01 /
DELANEY, JR., Joseph T. c/o Boston Scientific Scimed, Inc. One Scimed Place Maple Grove, Minnesota 55311 / US | 02 /
BODEN, Mark W. c/o Boston Scientific Scimed, Inc. One Scimed Place Maple Grove, Minnesota 55311 / US | 03 /
MURPHY, John c/o Boston Scientific Scimed, Inc. One Scimed Place Maple Grove, Minnesota 55311 / US | 04 /
MOLNAR, Viktoria c/o Boston Scientific Scimed, Inc. One Scimed Place Maple Grove, Minnesota 55311 / US | 05 /
DYNDIKOVA, Tatyana c/o Boston Scientific Scimed, Inc. One Scimed Place Maple Grove, Minnesota 55311 / US | 06 /
ZIPP, Allison c/o Boston Scientific Scimed, Inc. One Scimed Place Maple Grove, Minnesota 55311 / US | 07 /
KOLSTE, Kolbein K. c/o Boston Scientific Scimed, Inc. One Scimed Place Maple Grove, Minnesota 55311 / US | [2022/50] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE | [2022/50] | Application number, filing date | 21709178.4 | 02.02.2021 | [2022/50] | WO2021US16213 | Priority number, date | US202062969863P | 04.02.2020 Original published format: US 202062969863 P | [2022/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021158546 | Date: | 12.08.2021 | Language: | EN | [2021/32] | Type: | A1 Application with search report | No.: | EP4100072 | Date: | 14.12.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.08.2021 takes the place of the publication of the European patent application. | [2022/50] | Search report(s) | International search report - published on: | EP | 12.08.2021 | Classification | IPC: | A61L27/18 | [2022/50] | CPC: |
A61L27/18 (EP,US);
A61L27/16 (US);
A61L27/3839 (US);
A61L27/50 (US);
A61L2400/06 (EP);
A61L2430/34 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/50] | Title | German: | INJIZIERBARE IN VIVO VERNETZENDE MATERIALIEN ZUR VERWENDUNG ALS WEICHGEWEBE-FÜLLSTOFFE | [2022/50] | English: | INJECTABLE IN VIVO CROSSLINKING MATERIALS FOR USE AS SOFT TISSUE FILLERS | [2022/50] | French: | MATÉRIAUX DE RÉTICULATION IN VIVO INJECTABLES DESTINÉS À ÊTRE UTILISÉS EN TANT QUE CHARGES DE TISSUS MOUS | [2022/50] | Entry into regional phase | 29.08.2022 | National basic fee paid | 29.08.2022 | Designation fee(s) paid | 29.08.2022 | Examination fee paid | Examination procedure | 29.08.2022 | Examination requested [2022/50] | 29.08.2022 | Date on which the examining division has become responsible | 02.03.2023 | Amendment by applicant (claims and/or description) | 04.10.2024 | Despatch of a communication from the examining division (Time limit: M04) | 03.02.2025 | Reply to a communication from the examining division | 02.02.2026 | Communication of intention to grant the patent | Fees paid | Renewal fee | 22.02.2023 | Renewal fee patent year 03 | 20.02.2024 | Renewal fee patent year 04 | 18.02.2025 | Renewal fee patent year 05 | 19.02.2026 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X] EP2389925 (TYCO HEALTHCARE et al.) [X] 1-15 * page 2, paragraphs 0006, 0007 * * page 4, paragraph 0044 * * page 6, paragraph 0063 * * page 9, paragraph 0096 * |